368 related articles for article (PubMed ID: 16168665)
21. Modified haemagglutination inhibition assay for the detection of canine parvovirus type 2 antibodies in dog sera.
Cavalli A; Martella V; Desario C; Camero M; Lanave G; Barrs VR; Decaro N; Buonavoglia C
Vet J; 2021 Aug; 274():105709. PubMed ID: 34157378
[TBL] [Abstract][Full Text] [Related]
22. Passive protection of dogs against clinical disease due to Canine parvovirus-2 by specific antibody from chicken egg yolk.
Van Nguyen S; Umeda K; Yokoyama H; Tohya Y; Kodama Y
Can J Vet Res; 2006 Jan; 70(1):62-4. PubMed ID: 16548334
[TBL] [Abstract][Full Text] [Related]
23. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine.
Buonavoglia C; Tollis M; Buonavoglia D; Puccini A
Comp Immunol Microbiol Infect Dis; 1992 Oct; 15(4):281-3. PubMed ID: 1330425
[TBL] [Abstract][Full Text] [Related]
24. Serologic response of pups to the low-passage, modified-live canine parvovirus-2 component in a combination vaccine.
O'Brien SE
J Am Vet Med Assoc; 1994 Apr; 204(8):1207-9. PubMed ID: 8014088
[TBL] [Abstract][Full Text] [Related]
25. Simple tests for rapid detection of canine parvovirus antigen and canine parvovirus-specific antibodies.
Marulappa SY; Kapil S
Clin Vaccine Immunol; 2009 Jan; 16(1):127-31. PubMed ID: 18987166
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of the paramunity inducer PIND-ORF in the treatment of canine parvovirus infection.
Proksch AL; Unterer S; Truyen U; Hartmann K
Vet J; 2014 Nov; 202(2):340-7. PubMed ID: 25218850
[TBL] [Abstract][Full Text] [Related]
27. Coagglutination test: a simple and rapid immunodiagnostic test for parvovirus infection in dogs.
Singh BR; Yadav RC; Singh SP; Sharma VD
Indian J Exp Biol; 1998 Jun; 36(6):622-4. PubMed ID: 9731477
[TBL] [Abstract][Full Text] [Related]
28. Oral administration of modified live canine parvovirus type 2b induces systemic immune response.
Cavalli A; Desario C; Marinaro M; Losurdo M; Camero M; Decaro N; Catella C; Lanave G; Buonavoglia C
Vaccine; 2020 Jan; 38(2):115-118. PubMed ID: 31628031
[TBL] [Abstract][Full Text] [Related]
29. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
Larson LJ; Schultz RD
Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of antibodies to canine parvovirus and reaction to vaccination in client-owned, healthy dogs.
Riedl M; Truyen U; Reese S; Hartmann K
Vet Rec; 2015 Dec; 177(23):597. PubMed ID: 26514756
[TBL] [Abstract][Full Text] [Related]
31. Canine parvovirus infection: which diagnostic test for virus?
Desario C; Decaro N; Campolo M; Cavalli A; Cirone F; Elia G; Martella V; Lorusso E; Camero M; Buonavoglia C
J Virol Methods; 2005 Jun; 126(1-2):179-85. PubMed ID: 15847935
[TBL] [Abstract][Full Text] [Related]
32. [Case report: effect of maternal antibodies on the vaccination against canine parvovirus].
Schunck B; Truyen U
Tierarztl Prax; 1995 Apr; 23(2):185-6. PubMed ID: 7624862
[TBL] [Abstract][Full Text] [Related]
33. Vaccination of dogs with Duramune DAPPi+LC protects against pathogenic canine parvovirus type 2c challenge.
Wilson S; Stirling C; Borowski S; Thomas A; King V; Salt J
Vet Rec; 2013 Jun; 172(25):662. PubMed ID: 23748583
[TBL] [Abstract][Full Text] [Related]
34. Influence of clinical and laboratory variables on faecal antigen ELISA results in dogs with canine parvovirus infection.
Proksch AL; Unterer S; Speck S; Truyen U; Hartmann K
Vet J; 2015 Jun; 204(3):304-8. PubMed ID: 25920770
[TBL] [Abstract][Full Text] [Related]
35. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
36. A modified live canine parvovirus vaccine. II. Immune response.
Carmichael LE; Joubert JC; Pollock RV
Cornell Vet; 1983 Jan; 73(1):13-29. PubMed ID: 6337780
[TBL] [Abstract][Full Text] [Related]
37. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination.
Pollock RV; Carmichael LE
J Am Vet Med Assoc; 1982 Jan; 180(1):37-42. PubMed ID: 7056660
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies.
Martella V; Cavalli A; Decaro N; Elia G; Desario C; Campolo M; Bozzo G; Tarsitano E; Buonavoglia C
Clin Diagn Lab Immunol; 2005 Oct; 12(10):1243-5. PubMed ID: 16210491
[TBL] [Abstract][Full Text] [Related]
39. Immunodetection of Canine Parvovirus (CPV) in clinical samples by polyclonal antisera against CPV-VP2 protein expressed in Esherichia coli as an antigen.
Park JS; Choi BK; Vijayachandran LS; Ayyappan V; Chong CK; Lee KS; Kim SC; Choi CW
J Virol Methods; 2007 Dec; 146(1-2):281-7. PubMed ID: 17825928
[TBL] [Abstract][Full Text] [Related]
40. Monitoring of canine parvovirus (CPV) strains detected in vaccinated puppies in Brazil.
Castro TX; Costa EM; Leite JP; Labarthe NV; Cubel Garcia RC
Res Vet Sci; 2011 Apr; 90(2):336-40. PubMed ID: 20609453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
